Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Vorinostat in Combination With Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2016 by AIDS Malignancy Consortium
Sponsor:
Collaborators:
National Cancer Institute (NCI)
The EMMES Corporation
University of Arkansas
Information provided by (Responsible Party):
AIDS Malignancy Consortium
ClinicalTrials.gov Identifier:
NCT01249443
First received: November 25, 2010
Last updated: August 3, 2016
Last verified: August 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2021
  Estimated Primary Completion Date: July 2017 (Final data collection date for primary outcome measure)